[The vaccines against toxoplasmosis--current status of the studies].
The article presents current studies on the development of effective vaccines against toxoplasmosis new approaches and strategies to construct prophylactic and therapeutic vaccines using recombinant microorganisms expressing protective T. gondii antigens, parasite DNA or RNA and recombinant antigens.
Długońska
Henryka
H
Zakład Immunoparazytologii, Katedra Immunologii i Biologii Infekcyjnej, Uniwersytet Lódzki, ul. Banacha 12/16, 90-237 Łódź. hdlugo@biol.uni.lodz.pl
Gatkowska
Justyna
J
Kur
Józef
J
Gasior
Artur
A
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology* / Q000627:therapeutic use; D016054:DNA, Protozoan / Q000627:therapeutic use; D005260:Female; D006801:Humans; D051379:Mice; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000517:prevention & control*; D016053:RNA, Protozoan / Q000627:therapeutic use; D034561:Sheep, Domestic; D014122:Toxoplasma / Q000254:growth & development / Q000302:isolation & purification / Q000472:pathogenicity; D014123:Toxoplasmosis / Q000276:immunology / Q000517:prevention & control*; D014125:Toxoplasmosis, Congenital / Q000276:immunology / Q000517:prevention & control; D019444:Vaccines, DNA / Q000276:immunology / Q000627:therapeutic use*; D022223:Vaccines, Subunit / Q000276:immunology / Q000627:therapeutic use*; D014614:Vaccines, Synthetic / Q000276:immunology / Q000627:therapeutic use*
D000953:Antigens, Protozoan; D016054:DNA, Protozoan; D016053:RNA, Protozoan; D019444:Vaccines, DNA; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic